Paul Lancett

Creating an Antibacterial with in Vivo Efficacy: Synthesis and Characterization of Potent Inhibitors of the Bacterial Cell Division Protein FtsZ with Improved Pharmaceutical Properties

Ian Collins, James M. Bennett, L. Czaplewski, 2010, Journal of medicinal chemistry.

Design, synthesis and structure-activity relationships of substituted oxazole-benzamide antibacterial inhibitors of FtsZ.

D. Davies, L. Czaplewski, I. Collins, 2014, Bioorganic & medicinal chemistry letters.

Discovery and in vivo evaluation of alcohol-containing benzothiazoles as potent dual-targeting bacterial DNA supercoiling inhibitors.

J. Palmer, D. Davies, C. Morton, 2014, Bioorganic & medicinal chemistry letters.

Design, synthesis and biological evaluation of α-substituted isonipecotic acid benzothiazole analogues as potent bacterial type II topoisomerase inhibitors.

Edward M. Tyndall, J. Palmer, D. Davies, 2013, Bioorganic & medicinal chemistry letters.

DNA gyrase (GyrB)/topoisomerase IV (ParE) inhibitors: synthesis and antibacterial activity.

Paul N. Mortenson, L. Czaplewski, C. Smee, 2009, Bioorganic & medicinal chemistry letters.

Biological Evaluation of Benzothiazole Ethyl Urea Inhibitors of Bacterial Type II Topoisomerases

L. Czaplewski, C. Smee, I. Collins, 2013, Antimicrobial Agents and Chemotherapy.

Development and Characterization of a Human Hepatocyte Low Intrinsic Clearance Assay for Use in Drug Discovery

P. Barton, R. Riley, B. Williamson, 2018, Drug Metabolism and Disposition.